Release of clotting factors from photosensitized endothelial cells: A possible trigger for blood vessel occlusion by photodynamic therapy  by Ben-Hur, E. et al.
Volume 236, number 1, 105-108 FEB 06172 August 1988 
Release of clotting factors from photosensitized endothelial cells: a 
possible trigger for blood vessel occlusion by photodynamic 
therapy 
E. Ben-Hur, E. Heldman+, S.W. Crane” and I. Rosenthal* 
Nuclear Research Center-Negev, PO Box 9001, Beer-Sheva, +Israel Institute for Biological Research, PO Box 19, 
Nes-Ziona, Israel, “North Carolina State University, School of Veterinary Medicine, Raleigh, NC 27606, USA and 
*ARO. The Volcani Center, PO Box 6, Bet-Dagan, Israel 
Received 17 June 1988 
Photodynamic treatment of solid tumors results in the occlusion of blood vessels in the treated tissue. We hypothesize 
that this process is triggered by the release of one or more clotting factors from the photodamaged endothelial cells. 
Experimental evidence is presented that immediately after photodynamic treatment, cultured endothelial cells start releas- 
ing clotting factors into the medium in a dose range of minimal cytotoxicity. 
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1. INTRODUCTION 
Photodynamic therapy (PDT) is based on selec- 
tive retention of photosensitizing dyes in the tumor 
tissue. Subsequent illumination with red light, 
usually from a dye laser, results in tumor necrosis 
with little damage to the surrounding normal tissue 
[1,2]. The necrosis most probably results from oc- 
clusion of the blood vessels [3-71. The en- 
dothelium of blood vessels is quite sensitive to 
PDT [8] and plays an important role in the process 
of thrombus formation. Hence, it was reasonable 
to assume that the damage induced by photosen- 
sitization to endothelial cells causes the release of 
one or more clotting factors which trigger the pro- 
cess of thrombus formation and a subsequent 
blood flow stoppage. 
Endothelial cells from bovine adrenal medulla 
that develop capillary-like growth patterns and 
produce factor VIII [9] and other clotting factors 
in culture [lo] were chosen to test this hypothesis. 
Since it was recently shown that chloroaluminum 
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phthalocyanine tetrasulfonate (ClAlPCS), a new 
and attractive sensitizer for PDT [ 1 l-131, is effec- 
tive in stopping blood flow in experimental rat 
tumors [14], the release of clotting factors from 
these cells into the medium after photosensitiza- 
tion by ClAlPCS was investigated. The reason for 
performing this experiment was to understand 
some of the processes underlying photodynamic 
tumor destruction at the level of the blood supply 
to the tissue. 
2. EXPERIMENTAL 
Endothelial cells from bovine adrenal medulla [9], line EJG- 
HBP, were grown in culture as a monolayer in minimal essential 
medium (MEM) supplemented with 10% fetal calf serum, 
4 mM glutamine and antibiotics. The cells were harvested week- 
ly and split at a ratio of 1: 4. The cells doubled in number every 
1.5 days at 37°C in a humidified atmosphere containing 5% 
COr. The cells were plated in 50 mm Petri dishes at a density 
of 2 x lo5 cells per dish. 6 days after plating, when the cells 
reached confluency, ClAlPCS was added to the growth medium 
at a concentration of 4/M. Exposure to light was performed 
after additional incubation for 18 h with the dye. The light 
source was a bank of 40 W fluorescent tubular lamps (Sylvania, 
Daylight) held in a reflector. The fluence rate was 55 W. m-’ at 
the surface of the cell monolayer. 
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In the experiments with “Cr, following the incubation with 
the dye and Na”Cr04, and before exposure to light, the cells 
were rinsed three times with PBS and 2 ml Hank’s balanced salt 
solution (HBSS) containing glucose was added. For radioactivi- 
ty counting, samples of 1 ml of HBSS were transferred into 
counting vials together with 10 ml scintillation cocktail (In- 
stagel). The remainder of the HBSS solution was discarded, the 
dishes were air-dried, the cells solubilized with 1 ml of hyamine 
hydroxide for 1 h at 37°C and radioactivity was counted in 
10 ml toluene-based cocktail. 
Clotting factors were assayed using the activated partial 
thromboplastin time (APTT) [15]. Briefly, 0.1 ml of factor 
VIII-deficient plasma was incubated at 37’C with 0.1 ml APTT 
reagent and 0.1 ml of cell extract. Following the incubation, 
0.1 ml of 25 mM CaClz was added to the reaction mixture and 
the time required to form a firm clot was measured using a 
coagulation timer. The clotting time of a test sample was con- 
verted to % clotting factor activity from a calibration curve ob- 
tained with normal human plasma. APTT reagent, normal 
human and factor VIII:C-deficient plasma were from Sigma 
Diagnostics. 
3. RESULTS AND DISCUSSION 
The effect of photosensitization by ClAlPCS on 
the growth of endothelial cells was studied over a 
range of light fluence values. As shown in fig. 1, a 
low light dose (20 kJ . m-*) resulted in only a slight 
reduction in growth rate. However, following 
higher doses (e.g. 40 kJ .rnm2) cell growth stopped 
completely, while at a fluence of 60 kJ. me2 the 
cells slowly disintegrated. Consistently, parallel 
assays in which we also measured the ability of the 
cells to divide and form colonies revealed cell 
deaths of 20% and 95% after light doses of 20 and 
40 kJ . mm2, respectively. 
Damage to plasma membrane of cells occurring 
over a shorter time period can be often assessed by 
loading cells with 51Cr, and following release of 
label after a specific treatment. We therefore load- 
ed endothelial cells with “Cr and ClAlPCS. 
Following a challenge with 82 kJ . me2 of light we 
measured the kinetics of “Cr release. As shown in 
fig.2, “Cr was released slowly in the absence of 
light exposure, reaching 50% of total label by 
nearly 2 h. However, following the light exposure, 
release of %r was substantially more robust, 
reaching 50% in -30 min. Therefore, photody- 
namic damage affecting nearly all the cells could 
be induced over a fairly short time. 
The exposure of ClAlPCS-treated endothelial 
cells to light also released factors capable of induc- 
ing blood clotting. It was possible that simple 
destruction of the cells and concomitant release of 
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Fig. 1. Photosensitized inhibition of endothelial cell growth. 
Bovine endothelial cells were plated at -1 x 10’ cells per 50 mm 
Petri dish. 1 day after plating, 4 yM ClAlPCS was added into 
the growth medium. 18 h later the medium was replaced with 
phosphate buffered saline (PBS) and the cells exposed to graded 
light fluences, as indicated (O-60 kJ .mm2). The growth medium 
was then readded and the cell number per dish determined at 
intervals by trypsinization and counting with a hemocytometer. 
cellular contents could be solely responsible for 
this observation. Therefore, to test this possibility 
we performed parallel kinetic experiments measur- 
ing clotting factor release from ClAlPCS- and 
“Cr-loaded endothelial cells. As shown in fig.2, 
virtually no clotting factors were released in the 
dark. However, after light treatment, -50% of the 
clotting factor activity was promptly released. In 
this case, the release reaction was virtually com- 
plete in less than 15 min. We concluded from these 
data that the photodynamic damage leading to 
release of “Cr occurred by a mechanism 
qualitatively different from that inducing clotting 
factor release. 
The dose-response curves for “Cr release and 
clotting factor release at 4°C and 37°C also seem 
to bear out this conclusion. As shown in fig.3A 
and B, little photodynamic release of either 51Cr or 
clotting factors was observed at 4°C. However, at 
37°C substantial release of both substances oc- 
curred. Nonetheless, the energy needed to stim- 
ulate “Cr to 50% of maximum (-60 kJ .mV2) was 
much greater than the energy needed to stimulate 
clotting factor release to a similar extent (-20 
kJ* me2). Evidently, the release of “Cr is not as 
sensitive a criterion to cytotoxicity as is release of 
clotting factors. Thus, following a dose that kills 
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Fig.2. Kinetics of photosensitized-induced release of “Cr and 
clotting factors. Confluent cultures of endothelial cells in 
50 mm Petri dishes were incubated for 18 h with 4 pM 
ClAlPCS and 1 &i/ml ‘Cr. The cells were then rinsed with 
PBS and 2 ml (for 51Cr) or 0.5 ml (for clotting factors), Hank’s 
balanced salt solution (HBSS) containing glucose was then 
added. The plates were either exposed to 82 kJ.m-* (filled 
symbols) or kept in dark (open symbols) at 23”C, and then 
incubated for various times at 37°C prior to assay of 51Cr (II,=) 
or clotting factor release (A, A) as described in section 2. 
95% of the cells (40 kJ . me2) there was only 20% 
release of %r, while the release of clotting factors 
occurs in the biological dose range, saturating at 
-50 kJ.me2 (fig.3). 
The mechanism of clotting factor release by en- 
dothelial cells is probably an active process (it does 
not occur at lower temperature), triggered by 
ClAlPCS-induced photodamage. In general, there 
are two pathways of protein secretion by 
eukaryotic cells: one is constitutive secretion and 
the other is regulated secretion [16]. Constitutive 
secretion occurs as soon as the protein is synthe- 
sized and transported to the cell surface. The 
regulated secretion involves the formation of a 
secretory vesicle that is released after an ap- 
propriate stimulus. These processes were shown to 
occur in cultured endothelial cells for von 
Willebrand’s factor [17], which serves as a carrier 
for factor VIII:C in the plasma. In this case, 
regulated release was induced by thrombin or Ca2+ 
ionophore A23187. The induced release of von 
Willebrand’s factor from the storage sites in en- 
dothelial cells is evoked within 10 min by various 
stimulators [ 18,191. Photosensitization might in- 
terfere with the regulating mechanism of the clot- 
ting factors’ secretion, resulting in massive release 
of these factors. 
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Fig.3. (A) Photosensitized-induced release of ‘rCr. For details 
see legend to fig.2. The plates were exposed to graded light 
fluences at room temperature and then incubated for 1 h at 
37°C (0) or 4°C (*). Triplicate dishes were used per data-point 
and the results are the mean value. SE were smaller than the 
symbols. Results are expressed as % activity released into 
medium after subtracting the value of unirradiated control 
(26%). (B) Photosensitized-induced release of clotting factors. 
Confluent cultures of endothelial cells in 50 mm Petri dishes 
were incubated with 4pM ClAlPCS for 18 h. The cells were 
then rinsed with PBS and 0.5 ml HBSS was added. The plates 
were exposed to graded light fluences at room temperature (0) 
or 4°C (*) and incubated for 10 min at 37°C (0) or 4°C (+). 
The solutions from two replicate plates were pooled for clotting 
factor assay. Control, unirradiated dishes were used to 
determine spontaneous release, which was undetectable (see 
fig.2). To determine total activity, the cells were rinsed with 
PBS, freeze-dried at -20°C and then extracted with 0.5 ml 
HBSS for 1 h at 4°C. Results are expressed as percentage of 
total activity released into medium. Total activity was 8.5 + 
2.1% (using normal human plasma as 100%) in 1 x lo6 cells 
and 3 x lo6 cells were used per assay. Datapoints are the mean 
value * SE of three separate xperiments. 
The present data clearly indicate that exposure 
of endothelial cells loaded with the photosensitiz- 
ing drug ClAlPCS results in light-induced secretion 
of clotting factor activity by a mechanism quite 
distinct from simple cell destruction. The reasons 
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for this conclusion include the fact that the time 
course of light-induced clotting factor secretion is 
appreciably faster than release of “Cr, and the fact 
that the energy profiles of both processes are dif- 
ferent. It is clear that at least two processes directly 
controlled by endothelial cells may lead to local 
blood clotting. One of these is the release of clot- 
ting factors, possibly including factor VIII:C. The 
second process is release of tissue factor by cell 
destruction. It is of course true that merely releas- 
ing factor VIII:C would not necessarily generate a 
local clot. However, activation of factor VIII:C in 
association with other processes cannot be exclud- 
ed. Finally, tissue factor by itself, acting on factor 
X, would directly cause clotting. The contributions 
of the different processes can presumably be 
distinguished by the differential time courses of 
clotting factor secretion and 51Cr secretion. 
We conclude that the basis for effective 
photodynamic therapy of tumors may indeed in- 
volve direct action on the level of endothelial cells 
lining the vessels and forming the capillaries in 
susceptible tumors. This is a novel finding, which 
we anticipate will prove important for devising 
more effective therapeutic protocols. 
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